Remepy has raised $36M in a Series A financing round [...]

AC Immune has received FDA Fast Track designation and IND [...]

BioVie has reported topline results from a Phase 2 trial [...]

AC Immune has outlined a series of clinical milestones expected [...]

ABLi Therapeutics has reported coordinated changes across 11 biomarkers linked [...]

Mission Therapeutics has signed a deal worth up to US$292 [...]

Remepy has published new peer-reviewed findings showing that its investigational [...]

Scenic Biotech has joined the Michael J. Fox Foundation’s LRRK2 [...]

Deep Science Ventures and Medicines Discovery Catapult have launched a [...]

AC Immune has initiated a Phase 1 trial of its [...]